Matches in Nanopublications for { ?s ?p "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP247573.RAQFikdwe2O0gWerAMQK9VPmQTMoiNVG7QJUduUDcAUDI130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247573.RAQFikdwe2O0gWerAMQK9VPmQTMoiNVG7QJUduUDcAUDI130_provenance.
- NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430393.RAaB9MXxkpz8uL9EW0B5qxCoqaUjZhbPFczVS-Mr_YN7Q130_provenance.
- NP256831.RAw72zHhISs8d_APyYqjc31zcsXlHYSwHnyNv8BhzERh8130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256831.RAw72zHhISs8d_APyYqjc31zcsXlHYSwHnyNv8BhzERh8130_provenance.
- NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584486.RA9gyiSmPrHoSNpDAhBfjeYDobLboCjoaI65L4VBsf2Ps130_provenance.
- NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_provenance.
- assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP982432.RAY9cMLY3J1B_xz2_IiEmTUD9uwI7wqB6_aGshpEildSU130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982432.RAY9cMLY3J1B_xz2_IiEmTUD9uwI7wqB6_aGshpEildSU130_provenance.
- NP882965.RAiJc-2pOSMqV1bejpXtzWlbAx3DO3oktzIgST8Vnvdoc130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882965.RAiJc-2pOSMqV1bejpXtzWlbAx3DO3oktzIgST8Vnvdoc130_provenance.
- NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_provenance.
- NP982430.RAhS8nxzpaUmr5E3cH7OsSKRAi-6GPX0dhH3sPrJg-oDo130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982430.RAhS8nxzpaUmr5E3cH7OsSKRAi-6GPX0dhH3sPrJg-oDo130_provenance.
- NP982429.RA9vJIQU0pdTInxc1jycRw8IS-bFNCAB2wD8Ojui9Gz7Q130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982429.RA9vJIQU0pdTInxc1jycRw8IS-bFNCAB2wD8Ojui9Gz7Q130_provenance.
- NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982431.RA78kvTvHnoaUB8XSm1xMZL_PTB9UwEXsSNA4JFACPuHE130_provenance.